Sarasota Memorial Hospital is among 100 sites testing a new device for long-term medication use for atrial fibrillation ...

The procedure was carried out by Orlando Health Heart and Vascular Institute cardiothoracic surgeon Dr Anthony Rongione.

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

As part of Methodist Hospital Texsan’s continued efforts to prevent strokes in South Texas, the hospital announced on Oct. 23 that its Cardiac Electrophysiology, EP, team has successfully performed ...

While short-term DOAC was not significantly better than dual antiplatelet therapy (DAPT) at preventing device-related ...

Recent findings may be relevant to discussions with patients and their families about the pros and cons of cardiac surgery.

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy technologies.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...

Holy Cross Health is adding to an already impressive list of heart and vascular care specialists with the announcement that ...